Egashira K, Kikuchi Y, Sagara T, Sugihara M, Nakamura M
Department of Internal Medicine, Kyushu Kohsei-Nenkin Hospital, Kitakyushu City, Japan.
Jpn Heart J. 1987 Nov;28(6):841-9. doi: 10.1536/ihj.28.841.
Long-term prognosis of 90 patients with vasospastic angina without significant coronary artery disease (less than 50% reduction in luminal diameter) was examined for a mean follow-up period of 4 years. All patients had episodes of angina at rest and were treated with calcium antagonists. One patient developed myocardial infarction and 2 died suddenly during the follow-up period. In the patient with myocardial infarction, there was an abrupt worsening of angina prior to the infarction despite therapy with a calcium antagonist. One of the sudden death patients discontinued his calcium antagonist before his death. Of the sudden death patients, one had ventricular tachycardia and the other had a complete atrioventricular block during an anginal attack. The incidence of such serious arrhythmias was higher (p less than 0.01) in sudden death patients (2/2) than that in survivors (6/88). The treatment with calcium antagonists reduced the severity and frequency of angina in all patients. These results suggest that long-term prognosis of vasospastic angina without significant coronary artery disease is good as characterized by the low incidence of myocardial infarction and death and the favorable response to treatment with calcium antagonists.
对90例无明显冠状动脉疾病(管腔直径减少小于50%)的血管痉挛性心绞痛患者进行了平均4年的随访,以研究其长期预后。所有患者均有静息性心绞痛发作,并接受了钙拮抗剂治疗。随访期间,1例患者发生心肌梗死,2例患者突然死亡。在发生心肌梗死的患者中,尽管接受了钙拮抗剂治疗,但在梗死前心绞痛仍突然加重。其中1例猝死患者在死亡前停用了钙拮抗剂。在猝死患者中,1例在心绞痛发作时出现室性心动过速,另1例出现完全性房室传导阻滞。猝死患者(2/2)中这种严重心律失常的发生率高于存活者(6/88)(p<0.01)。钙拮抗剂治疗降低了所有患者心绞痛的严重程度和发作频率。这些结果表明,无明显冠状动脉疾病的血管痉挛性心绞痛长期预后良好,其特征为心肌梗死和死亡发生率低,对钙拮抗剂治疗反应良好。